---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-044486"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T08:57:51.534316+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Femasys posts updated October 2024 investor presentation; no financial updates disclosed

## Summary
- Company made updated slide presentation available on its website for use in meetings with investors and analysts.
- Presentation reiterates focus on women's reproductive health innovation; no new financial guidance or material events disclosed.
- No specific numbers, new product approvals, or changes to outlook were included in the available excerpt.
- Filing is routine; confidence is low due to lack of full presentation content.

## SEC filing metadata
- accession: 0001140361-24-044486
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036124044486/0001140361-24-044486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036124044486/ef20037823_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-044486
- JSON: https://secwatch.observer/filing/0001140361-24-044486.json
- Plain text: https://secwatch.observer/filing/0001140361-24-044486.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.